We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Monitoring Technology Keeps COVID-19 Vaccines Safe

By HospiMedica International staff writers
Posted on 01 Dec 2020
An automated environmental monitoring platform can help administrators prepare for the pending global rollout of COVID-19 vaccines.

The Primex (Lake Geneva, WI, USA) OneVue Sense sensor incorporates a cryogenic probe that can monitor storage units for temperatures as low as minus 200 degrees Celsius. More...
Once paired with the OneVue Monitor automated monitoring software solution, the integrated system provides real-time alerts if vaccine storage temperatures fluctuate outside of the specified temperature range, helping maintain vaccine safety and effectiveness. The system also archives all recorded temperatures to ensure compliance.

In addition to environmental temperature monitoring, the OneVue monitoring software also provides indoor air quality data, differential pressure reading, and contact closure monitoring solutions, which can be used to monitor hospital isolation rooms and to ensure that freezer storage doors remain closed. The cloud-based software powering the OneVue system is fully customizable, enabling users to schedule reports, alerts, and messaging to suit specific needs, and to synchronize many different types of devices across a facility.

“For nearly 50 years, healthcare providers have trusted Primex to deliver proven and reliable healthcare solutions. We are proud to be part of this monumental public health effort to ensure safe, reliable, and effective COVID-19 vaccines reach the public,” said Paul Shekoski, CEO of Primex. “Any breach in temperature control can degrade a vaccine, making it lose its full potency. With the Primex OneVue platform, customers have peace of mind knowing that the vaccine will always remain at the proper temperature.”

The current leading COVID-19 vaccine candidates are expected to require extremely cold storage temperatures, with some, such as the Pfizer (New York, NY, USA) candidate, requiring storage and triage at temperatures as low as minus 70 degrees Celsius.

Related Links:
Primex
Pfizer



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Pediatric Mask
Respire SOFT
New
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.